Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 28332 | 170 | 27.1 | 58% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 1350 | 7838 | KAPOSIS SARCOMA//HUMAN HERPESVIRUS 8//KSHV |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | AOTUS NANCYMAAE | Author keyword | 3 | 38% | 4% | 6 |
| 2 | AOTUS | Author keyword | 1 | 11% | 5% | 8 |
| 3 | COLOMBIAN PERUVIAN AMAZON | Author keyword | 1 | 50% | 1% | 1 |
| 4 | EMERGING REEMERGING DIS UNIT | Address | 1 | 50% | 1% | 1 |
| 5 | IMMUNOL ONCOVIROL | Address | 1 | 50% | 1% | 1 |
| 6 | MALARIA TRAINING CPD MAL | Address | 1 | 50% | 1% | 1 |
| 7 | PATHOL MED BIOCHEM | Address | 1 | 50% | 1% | 1 |
| 8 | REFERENCE MALARIA EXTRA AMAZONIAN REG SECRETA | Address | 1 | 50% | 1% | 1 |
| 9 | STATE MED PRIMATOL | Address | 1 | 50% | 1% | 1 |
| 10 | T CELL RECEPTOR BETA VARIABLE | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | AOTUS NANCYMAAE | 3 | 38% | 4% | 6 | Search AOTUS+NANCYMAAE | Search AOTUS+NANCYMAAE |
| 2 | AOTUS | 1 | 11% | 5% | 8 | Search AOTUS | Search AOTUS |
| 3 | COLOMBIAN PERUVIAN AMAZON | 1 | 50% | 1% | 1 | Search COLOMBIAN+PERUVIAN+AMAZON | Search COLOMBIAN+PERUVIAN+AMAZON |
| 4 | T CELL RECEPTOR BETA VARIABLE | 1 | 50% | 1% | 1 | Search T+CELL+RECEPTOR+BETA+VARIABLE | Search T+CELL+RECEPTOR+BETA+VARIABLE |
| 5 | BLOCK DUPLICATION | 0 | 25% | 1% | 1 | Search BLOCK+DUPLICATION | Search BLOCK+DUPLICATION |
| 6 | CLOSED LOOP ANESTHESIA | 0 | 25% | 1% | 1 | Search CLOSED+LOOP+ANESTHESIA | Search CLOSED+LOOP+ANESTHESIA |
| 7 | HUMAN T CELL LEUKEMIA VIRUS 1 HTLV 1 | 0 | 25% | 1% | 1 | Search HUMAN+T+CELL+LEUKEMIA+VIRUS+1+HTLV+1 | Search HUMAN+T+CELL+LEUKEMIA+VIRUS+1+HTLV+1 |
| 8 | IL 2 IL 2R | 0 | 25% | 1% | 1 | Search IL+2+IL+2R | Search IL+2+IL+2R |
| 9 | IN VIVO DEPLETION | 0 | 25% | 1% | 1 | Search IN+VIVO+DEPLETION | Search IN+VIVO+DEPLETION |
| 10 | ASEXUAL BLOOD STAGE | 0 | 20% | 1% | 1 | Search ASEXUAL+BLOOD+STAGE | Search ASEXUAL+BLOOD+STAGE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CHAIN V | 6 | 53% | 5% | 8 |
| 2 | NANCYMAAE | 5 | 63% | 3% | 5 |
| 3 | AOTUS INFULATUS | 1 | 50% | 1% | 1 |
| 4 | AOTUS NANCYMAAE | 1 | 22% | 1% | 2 |
| 5 | INFLUENZAE B POLYSACCHARIDE | 0 | 33% | 1% | 1 |
| 6 | MALARIA VACCINE DEVELOPMENT | 0 | 13% | 1% | 2 |
| 7 | ILLEGAL TRADE | 0 | 20% | 1% | 1 |
| 8 | MONOCLONAL ANTI CD4 | 0 | 17% | 1% | 1 |
| 9 | NANCYMAI MONKEYS | 0 | 17% | 1% | 1 |
| 10 | E ROSETTE FORMATION | 0 | 13% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| ANTIBODY-MEDIATED PROTECTION IN EXPERIMENTAL PLASMODIUM-FALCIPARUM MALARIA IN THE SAIMIRI MONKEY - STUDIES ON IMMUNE EFFECTOR BLOOD-CELLS | 1993 | 2 | 79 | 15% |
| MECHANISMS OF VIRAL TUMORIGENESIS | 1982 | 7 | 89 | 3% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | EMERGING REEMERGING DIS UNIT | 1 | 50% | 0.6% | 1 |
| 2 | IMMUNOL ONCOVIROL | 1 | 50% | 0.6% | 1 |
| 3 | MALARIA TRAINING CPD MAL | 1 | 50% | 0.6% | 1 |
| 4 | PATHOL MED BIOCHEM | 1 | 50% | 0.6% | 1 |
| 5 | REFERENCE MALARIA EXTRA AMAZONIAN REG SECRETA | 1 | 50% | 0.6% | 1 |
| 6 | STATE MED PRIMATOL | 1 | 50% | 0.6% | 1 |
| 7 | FIDIC | 1 | 15% | 2.4% | 4 |
| 8 | MED PARASITOL BIOL INFECT | 0 | 33% | 0.6% | 1 |
| 9 | PATHOBIOL IMMUNOBIOL | 0 | 33% | 0.6% | 1 |
| 10 | SEKIP UNIT 2 | 0 | 33% | 0.6% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000255302 | DOUBLE POSITIVE T CELLS//CD4CD8 T CELLS//CD8 INFECTION |
| 2 | 0.0000165203 | TYPE D RETROVIRUSES//TYPE D SIMIAN RETROVIRUS//SRV 2 |
| 3 | 0.0000101518 | HERPESVIRUS SAIMIRI//KLIN MOL VIROL//STPC |
| 4 | 0.0000098992 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |
| 5 | 0.0000088254 | POLLEN PEPTIDE//L 4 OXALYSINE//ALPHA ANORDRIN |
| 6 | 0.0000086044 | T11TS//CD2//CD58 |
| 7 | 0.0000085662 | CYSTIC RETE OVARII//SPONTANEOUS PATHOLOGY//AOTUS NANCYMAE |
| 8 | 0.0000078167 | HEMOPOESIS//ANTIGEN SPECIFIC PROLIFERATION//COLONY FORMING ACTIVITY |
| 9 | 0.0000075419 | MAJOR HISTOCOMPATIBILITY COMPLEX//MHC//BALANCING SELECTION |
| 10 | 0.0000069328 | COAT CONDITION//LIB VET MED//VESICULAR DERMATITIS |